http://globenewswire.com/news-release/2014/02/03/606663/0/en/DGAP-News-Alphaform-AG-Alphaform-announces-extensive-realignment.html
DGAP-News: Alphaform AG: Alphaform announces extensive realignment
February 03, 2014 04:44 | Source: Equity Story
DGAP-News: Alphaform AG / Key word(s): Profit Warning
Alphaform AG: Alphaform announces extensive realignment
03.02.2014 / 10:43
---------------------------------------------------------------------
Corporate News Announcement
Alphaform AG
Alphaform announces extensive realignment
- Restructuring, process improvement and competence extension as
pre-requirement for further growth
- Operational results forecast for 2013 is concretized at EUR-2.5 million
- CEO gets support from interim manager
Feldkirchen, 03rd February 2014 - The industrial 3D printing service provider Alphaform AG plans an extensive realignment. This is necessary due to the rapid technological development that threatened to overtake the company during the past business year. In the future, the company will focus on the 3D printing main business and on the creation of additional customer benefits. The realignment is accompanied by a restructuring in the organisation. It comprises the optimization of the operational processes for recovering the profitability, the expansion of the sales activities to increase revenues, as well as the enhancement of the own engineering competences in order to use the growth chances in 3D printing.
The operational business will focus on a faster order addressing and a better machine utilization with lower unit costs. Sales activity through Key Account Management is further enhanced and additionally sales channels e.g. online shopping and regional sales will be implemented. The first steps were already introduced during the 4th quarter in 2013. In the future, we will offer a more intensive engineering support - principally in 3D print-design - to the increasing number of customers, who are interested
in using 3D printing in their production.
Realignment and restructuring became necessary, when it became apparent that Alphaform also forfeited to the earnings in the fourth quarter, although the main business with prototypes and small series recovered to a satisfactory level again. The analysis for this reason was -among others - the reluctance to invest in the past, which led to increasing costs in material and labour force and to a restricted use of the machinery.
According to the further decline in revenues in the fourth quarter of 2013 and the additional costs for the introduction of the realignment, Alphaform concretises its present revenues forecast for the business year 2013 from EUR-1.2 million to now EUR-2.5 million. Additionally, goodwill amortizations at the implants subsidiary MediMet and individual impairment (Einzelwertberichtigungen) are expected, which amount is not yet finally determined. The revenues forecast of approx. EUR26 million is achieved.
Corporate Office extended
In order to push along the realignment, the Executive Board promoted the
interim manager Dr. Hanns-Dieter Aberle. Aberle worked in the past eight
years as consultant and interim manager for mid-sized enterprises in machine and plant construction, primarily in the areas industrial laser technique and 3D printing, as well as in the segments portfolio management, sales and innovation management.
During the restructuring phase, the finance area is reinforced advisory by an experienced interim manager, Götz Ganghofer. Ganghofer has many years of experience in restructuration and finance management.
About Alphaform
Alphaform AG, based in Feldkirchen near Munich was founded in 1996. The company belongs to the European market leaders in the production of complex components means additive manufacturing, which are often grouped together under the term '3D printing'. An important mainstay of the segment 3D Printing and Additive Manufacturing is the production of series close prototypes, particularly for the automotive and capital goods industries. The Medical Division of Alphaform has a leading position throughout Europe in manufacturing and processing orthopaedic implants and instruments. The shares of Alphaform are listed in the Prime Standard Segment of the Frankfurt Stock Exchange (FWB) under the abbreviation ATF.
The core competence of Alphaform lies in its extensive application know-how for processes and materials for the additive production of complex prototypes, tools, individual components and small series made of plastic and metal. The company's activity is focused on the orthopaedic and medical technology, automotive, aviation and aerospace industries. The subsidiaries of Alphaform are located in Germany, Finland, Sweden and the UK.
Contact:
Dr. Thomas Vetter
CEO
ALPHAFORM AG
KapellenstraÃ?e 10
85622 Feldkirchen
Tel.: +49 89 905002 21
Fax: +49 89 9050021021
email: tvetter@alphaform.de
Internet: www.alphaform.de
News 
Market Data 
Discover 
